Genetics of cardiomyopathy risk in cancer survivors differ by age of onset (IMAGE)
Caption
In research published in JAMA Network Open, corresponding author Yadav Sapkota, PhD (center), and co-first authors Kateryna Petrykey, PhD (left), and Achal Neupane, PhD (right), all St. Jude Department of Epidemiology and Cancer Control, showed how common variants in the genes for titin and BAG3 were linked with decreased late-onset cancer therapy-related cardiomyopathy and rare variants in these genes showed no association.
Credit
St. Jude Children's Research Hospital
Usage Restrictions
No cropping
License
Original content